BENJAMIN KILPATRICK: Open Payments
NPI 1487055091 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,276 in 116 payments from 20 companies in 2025. Trend: 2023 $930 · 2024 $1,255 · 2025 $2,276
Food & beverage: $2,163Education: $113
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 22 | $314 |
| ABBVIE INC. | 21 | $301 |
| Regeneron Healthcare Solutions, Inc. | 14 | $295 |
| UCB, Inc. | 13 | $294 |
| LEO Pharma Inc. | 10 | $246 |
| Janssen Biotech, Inc. | 5 | $178 |
| GENZYME CORPORATION | 4 | $84 |
| Incyte Corporation | 3 | $81 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $77 |
| PFIZER INC. | 4 | $70 |
Products named: DUPIXENT, OTEZLA, SKYRIZI, Bimzelx, TREMFYA, ADBRY, OPZELURA, ANZUPGO.
Industry payments across GA — which companies pay providers there.
